According to a new report, published by KBV research, The Global Cold And Flu Supplements Market size is expected to reach $35.5 billion by 2030, rising at a market growth of 11.9% CAGR during the forecast period.
The Vitamins & Minerals segment is leading the Global Cold And Flu Supplements Market by Product in 2022; thereby, achieving a market value of $14.1 billion by 2030. Vitamins & minerals are essential to maintain the immune system and general health. They are, therefore, often used in cold and flu supplements to increase immunity and speed up recovery. Due to growing consumer awareness of the value of these nutrients in preserving good health, the demand for vitamin & mineral-based cold and flu supplements has shown consistent growth.
The Online segment is experiencing a CAGR of 13% during (2023 - 2030). Online distribution platforms provide customers with unprecedented accessibility and convenience. With just a few clicks, they enable people to browse various cold and flu supplements at home or on the road. Online stores are accessible around the clock, allowing customers to buy supplements when and where they want. In recent years, selling cold and flu supplements through internet channels has expanded dramatically because of this convenience.
The Asia Pacific region dominated the Global Cold And Flu Supplements Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $10.0 billion by 2030. The North America region is anticipated to grow at a CAGR of 11.4% during (2023 - 2030). Additionally, The Europe region would register a CAGR of 11.7% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/cold-and-flu-supplements-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
By Product
By Distribution Channel
By Geography
Companies Profiled
Unique Offerings 
